Adalimumab-adaz Injection Shortage
Last Updated: April 14, 2025
Status: Discontinued
To Be Discontinued:
- Hyrimoz, Injection, 10 mg/.1 mL (Sandoz Inc.)
- Hyrimoz, Injection, 20 mg/.2 mL (Sandoz Inc.)
- Hyrimoz, Injection, 80 mg/.8 mL (Sandoz Inc.)
Hyrimoz, Injection, 10 mg/.1 mL (Sandoz Inc.)
NDC Code: 61314-509-64Status: To Be Discontinued
Date of update: April 14, 2025
Update type: New
Therapeutic category: Rheumatology
Date discontinued: April 14, 2025
Initial posting date: April 14, 2025
Contact info: 800-525-8747
Hyrimoz, Injection, 20 mg/.2 mL (Sandoz Inc.)
NDC Code: 61314-476-64Status: To Be Discontinued
Date of update: April 14, 2025
Update type: New
Therapeutic category: Rheumatology
Date discontinued: April 14, 2025
Initial posting date: April 14, 2025
Contact info: 800-525-8747
Hyrimoz, Injection, 80 mg/.8 mL (Sandoz Inc.)
NDC Code: 61314-454-20Status: To Be Discontinued
Date of update: April 14, 2025
Update type: New
Therapeutic category: Rheumatology
Date discontinued: April 14, 2025
Initial posting date: April 14, 2025
Contact info: 800-525-8747
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.